Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-253,540
Closed -$6.3M 161
2025
Q4
$6.3M Hold
253,540
0.37% 94
2025
Q3
$5.89M Hold
253,540
0.41% 89
2025
Q2
$5.61M Buy
253,540
+25,209
+11% +$588K 0.39% 93
2025
Q1
$5.62M Sell
228,331
-30,795
-12% -$806K 0.45% 83
2024
Q4
$6.87M Hold
259,126
0.46% 78
2024
Q3
$7.48M Buy
259,126
+37,831
+17% +$1.1M 0.5% 78
2024
Q2
$6.19M Buy
221,295
+1,771
+0.8% +$48.8K 0.55% 70
2024
Q1
$6.09M Buy
+219,524
New +$6.09M 0.52% 79

Other funds holding PFE

Sienna Gestion's PFE Position: Q1 2026 in Review

Sienna Gestion sold out of Pfizer (PFE) in Q1 2026, closing a stake of 253,540 shares — an estimated $6.3M sold.

Sienna Gestion first reported a position in PFE in Q1 2024 and held it in 8 quarters. The position peaked at $7.48M in Q3 2024. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Sienna Gestion reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Sienna Gestion sold 253,540 Pfizer shares in Q1 2026, an estimated $6.3M.
  • Sienna Gestion first reported a position in Pfizer in Q1 2024 and held it in 8 quarters.
  • Sienna Gestion's Pfizer position peaked at $7.48M in Q3 2024.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Sienna Gestion's 13F filing for Q1 2026, filed 15 May 2026.